Tech Company Financing Transactions
Roka Bioscience Funding Round
On 6/28/2013, Roka Bioscience raised $25 million in Series E financing from private investors.
Transaction Overview
Company Name
Announced On
6/28/2013
Transaction Type
Venture Equity
Amount
$24,999,999
Round
Series E
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
20 Independence Blvd. 4th Floor
Warren, NJ 07059
USA
Warren, NJ 07059
USA
Phone
Website
Email Address
Overview
Roka Bioscience (NASDAQ: ROKA) is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mary Duseau
Chief Financial Officer
Lars Boesgaard
Chief Scientific Officer
Michael Becker
Vice President
Erin Dreyling
VP - Manufacturing
David Patterson
VP - Sales
Kevin Giroux
Browse more venture capital transactions:
Prev: 6/28/2013: Recombinetics venture capital transaction
Next: 6/28/2013: Middle Peak Medical venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs